Companies tout a novel payment model for obesity drugs, other medications in drive to lower costs The approach, which allows employers to subsidize costs outside insurance, draws skeptics too

https://www.statnews.com/2025/10/22/startups-mix-lower-insurance-premiums-with-subsidized-cash-drug-purchases/